South Tees Hospitals NHS Foundation Trust

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Cervical cancer1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Diabetic foot ulcer1 trial
• Heart failure1 trial
• Lupus (SLE)1 trial
• Parkinson disease1 trial
• Peripheral artery disease1 trial
• Stroke1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Completed4 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Cambridge University Hospitals NHS Foundation Trust1 trial
• Canadian Cancer Trials Group1 trial
• Icahn School of Medicine at Mount Sinai1 trial
• Imperial College London1 trial
• South Tees Hospitals NHS Foundation Trust1 trial
• and 2 more

Running trials

• Recruiting

  Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  NCT04045665· Phase 3· Icahn School of Medicine at Mount Sinai· Source

  Contact: Lynn Whitehouse

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· The University of Queensland· Source

  Contact: Neil Hoye, Dr

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Chronic kidney disease1 recruiting
• Stroke1 recruiting

Closed trials

• Terminated

  Senescence in Myocardial Infarction

  NCT07693712· South Tees Hospitals NHS Foundation Trust· Source

• Completed

  Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes

  NCT05009602· Imperial College London· Source

• Completed

  PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

  NCT04870333· Phase 2/3· Cambridge University Hospitals NHS Foundation Trust· Source

• Completed

  CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

  NCT04226248· Phase 3· University of Bristol· Source

• Completed

  Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

  NCT01658930· Canadian Cancer Trials Group· Source